Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05701085 · ClinicalTrials.gov registry record · NA
Patient Navigator PRE-ACT Educational Intervention to Promote Decision Making Among Minorities
A NA study of Educational Intervention and Minorities, sponsored by Case Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT05701085: Recruiting NA study of Educational Intervention and Minorities, sponsored by Case Comprehensive Cancer Center.
NCT05701085 is a NA study of Educational Intervention and Minorities that is actively recruiting participants, run by Case Comprehensive Cancer Center. The registered enrollment target is 240 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05701085, a NA study of Educational Intervention and Minorities, is actively recruiting participants, sponsored by Case Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
This study focuses on psychosocial barriers at the patient level with the goal of promoting high quality decision making around clinical trials participation. The proposed study adapts the PRE-ACT model to racial and ethnic minority patients who were underrepresented in the original PRE-ACT study and will be combined with a patient navigator model.
Primary Outcome
Change in knowledge regarding cancer clinical trials after the intervention will be assessed by change in Pre and Post Intervention Survey Knowledge Score (scored from Items 1-8) with a higher score correlating to a greater change in knowledge.
Conditions Studied
Interventions
- OTHER Educational Intervention
Study Locations (1)
Ohio
- University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2023-04-24 |
| Est. Completion | 2026-12-30 |
| Phase | NA |
What NCT05701085 shows while recruiting
NCT05701085 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 2 conditions, with Educational Intervention appearing as the primary indexed condition, and to 1 intervention - of which Educational Intervention is the first listed.
NCT05701085 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05701085 about?
NCT05701085 is a clinical study titled "Patient Navigator PRE-ACT Educational Intervention to Promote Decision Making Among Minorities". This study focuses on psychosocial barriers at the patient level with the goal of promoting high quality decision making around clinical trials participation. The proposed study adapts the PRE-ACT model to racial and ethnic minority patients who were underrepresented in the original PRE-ACT study an...
What is the current status of trial NCT05701085?
This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2023-04-24. Estimated completion is 2026-12-30.
What conditions does trial NCT05701085 study?
This clinical trial studies the following conditions: Educational Intervention, Minorities.
What interventions are being tested in trial NCT05701085?
The interventions under investigation include: Educational Intervention (OTHER).
Who is sponsoring clinical trial NCT05701085?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05701085 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05701085's enrollment target sits among peer trials
240 440th of 2000 higher than 1,543 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI